MyJournals Home  

RSS FeedsIxazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance (Leukemia)

 
 

30 january 2019 18:00:02

 
Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance (Leukemia)
 




 
79 viewsCategory: Pathology
 
Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells (Leukemia)
A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination (Leukemia)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten